首页> 美国卫生研究院文献>Iranian Journal of Pharmaceutical Research : IJPR >Design Synthesis and Anti-Tubercular Activity of Novel 1 4-Dihydropyrine-3 5-Dicarboxamide Containing 4(5)-Chloro-2-Ethyl- 5(4)-Imidazolyl Moiety
【2h】

Design Synthesis and Anti-Tubercular Activity of Novel 1 4-Dihydropyrine-3 5-Dicarboxamide Containing 4(5)-Chloro-2-Ethyl- 5(4)-Imidazolyl Moiety

机译:新型的含4(5)-氯-2-乙基-5(4)-咪唑基部分的14-二氢比林-35-二甲酰胺的设计合成和抗管状活性

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Current researches have showed that N3, N5-diaryl-2, 6-dimethyl -1, 4-dihydropyrine-3, 5- dicarboxamide analogues demonstrate notable anti-tubercular activity. In this study, Hantzsch condensation was used to design and synthesize new analogues of dihydropyridine (DHP). Different diary carboxamides were inserted at positions 3 and 5 of the DHP ring. 4(5)-chloro-2-ethyl-5(4)-imidazolyl moiety was considered at position 4 of the DHP ring. The structures of prepared ligands were characterized using TLC followed by FT-IR, elemental analysis, Mass and proton NMR. Results of anti-tubercular activity have indicated all the prepared ligands 3a-f inhibit the mycobacterium tuberculosis growth and the most potent compounds were 3c (3,4-Cl) and 3b (4-Cl). The in-vitro obtained data are agreement with our computational predictions in terms of partial atomic charge of carbonyl moieties at the positions 3 and 5 of dihydropyridine ring and the logP of the molecules.
机译:当前的研究表明,N3,N5-二芳基-2、6-二甲基-1、4-二氢比林-3、5-二羧酰胺类似物表现出显着的抗结核活性。在这项研究中,Hantzsch缩合用于设计和合成新的二氢吡啶(DHP)类似物。将不同的日记羧酰胺插入DHP环的3和5位。在DHP环的4位认为4(5)-氯-2-乙基-5(4)-咪唑基部分。制备的配体的结构使用TLC,然后进行FT-IR,元素分析,质量和质子NMR进行表征。抗结核活性的结果表明,所有制备的配体3a-f均抑制结核分枝杆菌的生长,最有效的化合物是3c(3,4-Cl)和3b(4-Cl)。体外获得的数据与我们的计算预测一致,即在二氢吡啶环的3和5位上的羰基部分原子原子电荷和分子的logP。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号